Expression of Nogo-66 receptor in human astrocytoma is correlated with tumor malignancy

Molecular Biology Reports

Volumn 39, Issue 3, 2012, Pages 2625-2632

  Xiong, Nanxiang ^a   Shen, Jianying ^b   Li, Shuai ^a   Li, Junjun ^a   Zhao, Hongyang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Astrocytoma; Expression; Malignancy; Myelin; Nogo 66 receptor; Nogo A

Indexed keywords

MESSENGER RNA; NOGO 66 RECEPTOR; PROTEIN NOGO A;

ADULT; AGED; ARTICLE; ASTROCYTOMA; ASTROCYTOMA CELL; CANCER GRADING; CANCER INHIBITION; CONTROLLED STUDY; DISEASE ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ASTROCYTOMA; BLOTTING, WESTERN; CELL MOVEMENT; CHINA; DNA PRIMERS; EXTRACELLULAR MATRIX; FEMALE; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MYELIN PROTEINS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84863821653     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1015-8     Document Type: Article

References (23)

1. Brat DJ, Scheithauer BW, Fuller GN, Tihan T (2007) Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol 2007(17):319-324
2. Curran NM, Griffin BD, 'Toole DO, Brady KJ, Fitzgerald SN, Moynagh PN (2005) The synthetic cannabinoid R(?)WIN 55, 212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner. J Biol Chem. 280:35797-35806
3. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME (2000) Nogo-A is a myelinassociated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:434-439
4. Fournier AE, GrandPre T, Strittmatter SM (2001) Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409:341-346
5. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z (2002) p75 interacts with the Nogo receptor as a co-receptor for Nogo. MAG and OMgp, Nature 420:74-78
6. Wong ST, Henley JR, Kanning KC, Huang KH, Bothwell M, Poo MM (2002) A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 5:1302-1308
7. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB (2004) LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7:221-228
8. Montani L, Gerrits B, Gehrig BP, Kempf A, Dimou L, Wollscheid B, Schwab ME (2009) Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system. J Biol Chem. 2009(284):10793-10807
9. Hsieh SH, Ferraro GB, Fournier AE (2006) Myelin-associated inhibitors regulate cofilin phosphorylation and neuronal inhibition through LIM kinase and Slingshot phosphatase. J Neurosci 26:1006-1015
10. Pernet V, Joly S, Christ F, Dimou L, Schwab ME (2008) Nogo-A, myelin-associated glycoprotein differently regulate oligodendrocyte maturation, myelin formation. J Neurosci 28:7435-7444
11. Jurewicz A, Matysiak M, Raine CS, Selmaj K (2007) Soluble Nogo-A an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis. Neurology. 68:283-287
12. Kuhlmann T, Remington L, Maruschak B, Owens T, Brück W (2007) Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol 66:238-246
13. Liao H, Duka T, Teng FY, Sun L, Bu WY, Ahmed S, Tang BL, Xiao ZC (2004) Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. J Neurochem 90:1156-1162
14. World Medical Organization (1996) Declaration of Helsinki (1964). Br Med J 313:1448-1449
15. Sinicrope F, Ruan S, Cleary K, Stephens L, Lee J, Levin B (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55:237-241
16. Amberger VR, Hensel T, Ogata N, Schwab ME (1998) Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res 58:149-158
17. Liu R, Tian B, Gearing M, Hunter S, Ye K, Mao Z (2008) Cdk5- mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proc Natl Acad Sci USA. 105:7570-7575
18. Oertle T, van der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A, Huber AB, Simonen M, Schnell L, Brösamle C, Kaupmann K, Vallon R, Schwab ME (2003) Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 23:5393-5406
19. Hu F, Strittmatter SM (2008) The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J Neurosci 28:1262-1269
20. Markovic DS, Vinnakota K, Chirasani S, Synowitz M, Raguet H, Stock K, Sliwa M, Lehmann S, Kälin R, van Rooijen N, Holmbeck K, Heppner FL, Kiwit J, Matyash V, Lehnardt S, Kaminska B, Glass R, Kettenmann H (2009) Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc Natl Acad Sci USA. 106:12530-12535
21. D'Abaco GM, Kaye AH (2007) Integrins: molecular determinants of glioma invasion. J Clin Neurosci. 14:1041-1048
22. Tsatas D, Kanagasundaram V, Kaye A, Novak U (2002) EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines. J Clin Neurosci. 9:282-288
23. Tysnes BB, Mahesparan R (2001) Biological mechanisms of glioma invasion and potential therapeutic targets. J Neurooncol 53:129-147